AI-assisted, human-published
06/05/2025 /Funding Events
Allay Therapeutics Secures $57.5M Series D Funding to Advance Ultra-Sustained Analgesic Products
Allay completes Series D financing co-led by Lightstone Ventures and ClavystBio, appoints new Chairman of the Board, and introduces long-lasting pain relief platform.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com